Citation Impact
2 from Science/Nature 65 standout
Citing Papers
Nanomedicine Tumor Targeting
2024 Standout
Deciphering breast cancer: from biology to the clinic
2023 Standout
Works of V. Harvey being referenced
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)
2013 Standout
Author Peers
| Author | Oncology | PRM | Cancer Research | RNMI | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| V. Harvey | 806 | 197 | 506 | 256 | 22 | 1.1k | |
| Jere T. Koskinen | 5 | 11 | 13 | 405 | |||
| Prakash Koodathingal | 13 | 3 | 18 | 4 | 453 | ||
| Caitlin Fraser | 32 | 1 | 1 | 1 | 20 | 1.3k | |
| Steven Raemaekers | 4 | 82 | |||||
| John Tisdale | 6 | 226 |
All Works
Loading papers...